Literature DB >> 31803685

Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum lady.

Sohini Das1, Manoj Job1, Thomas Kodiatte2, Ramya Iyadurai1.   

Abstract

Intrahepatic cholangiocarcinoma is an uncommon malignancy which usually occurs in the 7th decade. Here we present a postpartum patient with fever, hepatomegaly, and ascites, who was diagnosed to have metastatic intrahepatic cholangiocarcinoma. Copyright:
© 2019 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  Cholangiocarcinoma; jaundice in pregnancy; pregnancy associated cancer

Year:  2019        PMID: 31803685      PMCID: PMC6881913          DOI: 10.4103/jfmpc.jfmpc_748_19

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

Cholangiocarcinoma accounts for 3% of gastrointestinal malignancies.[12] Median age of presentation is the 7th decade.[2] Occurrence of cholangiocarcinoma in a pregnant patient is uncommon, with few reported cases.[34567] Here we present a postpartum patient with cholangiocarcinoma.

Case Presentation

A 28-year-old lady presented with 1 week of high-grade fever on postpartum day 10. She had right upper abdominal pain and jaundice from week 20 of gestation. She had postprandial vomiting throughout pregnancy. She underwent regular antenatal checkups and fetal ultrasound scans during this pregnancy. Provisional diagnosis of acute fatty liver of pregnancy (AFLP) was made by her treating physician. She delivered via normal vaginal delivery at week 33. Abdominal distention, initially attributed to pregnancy, worsened after delivery. There was no loss of weight, melena, pruritus, or pale stools. She denied history of smoking, diabetes mellitus, hypertension, and malignancy in family members. Due to worsening symptoms she was referred to our hospital for evaluation. On examination, her pulse rate was 122/min and temperature 101F. Systemic examination revealed a hard liver palpable 12 cm below the right costal margin. Shifting dullness was present. Pelvic examination was normal. Differential diagnoses considered were infectious causes (liver abscess, malaria, endometritis) and non-infectious etiologies (Budd Chiari syndrome, AFLP). Neoplastic etiology was also considered due to chronic history of jaundice and abdominal pain. Blood investigations have been mentioned in Table 1. Ascitic fluid analysis revealed 240 cells/ml (neutrophils-24%, lymphocytes-76%), albumin and protein of 1.4 g/dl and 3.1 g/dl, respectively. Blood, urine, and ascitic fluid cultures did not reveal growth. Computed tomography (CT) scan showed hepatomegaly with multiple liver lesions, largest being 13 × 10 × 8 cm. Multiple lung nodules, enlarged lesser omental, para-aortic, aortocaval lymph nodes, and lytic lesion in the first lumbar vertebra were noted.
Table 1

Relevant laboratory investigations

TestPatient’s ValuesReference Range
Hemoglobin (gram/dl)8.511-15
Total Leucocyte Count (mm3)13,4004,400-11,000/µL
 Neutrophils8440-70%
 Lymphocytes820-40%
 Monocytes82-6%
Platelets3,42,0001.5-4.5 lacs/µL
Creatinine (mg/dL)0.520.5-1.4
Total bilirubin (mg/dl)0.500.5-1
Direct bilirubin0.350.5-1
SGOT (U/L)488-40
SGPT (U/L)315-35
Alkaline phosphatase (U/L)30240-125
Total protein (gram/dl)5.96-8.5
Albumin (gram/dl)2.13.5-5
Gamma-glutamyl transferase (U/L)106<55
Beta-HCG (mIU/ml)11<5
Carcinoembryonic Antigen11.5<5
Alpha-fetoprotein (IU/ml)29.6<5
HIV 1 and 2 antibodiesNon-reactive
Hepatitis B surface antigenNegative
Hepatitis C antibodyNegative
Relevant laboratory investigations Ultrasound-guided biopsy of the largest liver lesion was done. This was reported as cholangiocarcinoma [Figure 1]. Our final diagnosis was metastatic intrahepatic cholangiocarcinoma. Our patient was initiated on palliative chemotherapy with capecitabine and opted for follow-up at another center.
Figure 1

Photomicrograph depicting infiltrating malignant tumor glands (black arrow) of cholangiocarcinoma (400×, H and E)

Photomicrograph depicting infiltrating malignant tumor glands (black arrow) of cholangiocarcinoma (400×, H and E)

Discussion

Common causes of postpartum fever include endometritis, urinary tract infection, mastitis, and perineal/episiotomy site infections.[89] Cholangiocarcinoma presenting as postpartum fever is rare.[10] Risk factors for cholangiocarcinoma include primary sclerosing cholangitis, hepatobiliary flukes, bile duct cystic disorders, cirrhosis, diabetes mellitus, and obesity.[111213141516] Our patient was a 28-year-old female without any risk factors for cholangiocarcinoma. In our patient, ascitic fluid analysis was consistent with malignant ascites (low-serum ascites albumin gradient, high-ascitic fluid protein). Fever, though uncommon, has been reported in other cases of cholangiocarcinoma.[1718] Abdominal pain and jaundice are common symptoms of cholangiocarcinoma.[19] Clinical presentation of cholangiocarcinoma can mimic that of AFLP and HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) [Table 2].[46]
Table 2

Cholangiocarcinoma diagnosed in pregnancy/postpartum period

Clinical FeaturesCase 1 (Qasrawi et al.[4])Case 2 (Balderston et al.[6])Case 3 (Goswami et al.[7])
Age382322
Obstetric history4th pregnancyPrimigravidaNA
Symptoms and durationRUQ pain, dark urine - one weekVomiting, abdominal pain&Abdominal pain, weight loss, fever-three weeks
Gestation in weeks at symptom onset36262 weeks post-partum
Abnormal examination findingsPalpable liver, jaundiceRUQ mass, jaundice, new onset high blood pressureRUQ mass, jaundice
Onset of jaundice36 weeks of gestation26 weeks of gestation2 weeks postpartum
Laboratory investigations (Reference range):
Total bilirubin in mg/dL (0.5-1)6.43.6→5.117.3
Direct bilirubin in mg/dL5NA10.5
Aspartate Aminotransferase in Units/L (8-40)837095
Alanine Aminotransferase in Units/L (5-35)873170
Alkaline Phosphatase in Units/L (40-125)319NA680
Prothrombin Time with International Normalized ratio in seconds (11-13.5)17 and 1.4NA and 1.8NA
Imaging:
UltrasoundHepatomegaly with liver massLiver mass lesionDilated CBD with filling defect
Computed TomographyNANAIntramural lesions in CBD, cystic duct, gall bladder; dilated gallbladder and CBD
Magnetic Resonance ImagingMass lesions in the liver; intrahepatic biliary dilationNANA
Endoscopic Retrograde Cholangio-PancreatographyNot doneRight sided hepatic tumor; constriction of right biliary system and CBDDilated CBD with obstruction
Final DiagnosisIntrahepatic cholangiocarcinomaIntrahepatic cholangiocarcinomaBiliary intraductal neoplasm
OutcomeDied 6 months after diagnosisDied 3 weeks after diagnosisNA

&Symptom duration not available; NA-Details not available; CBD-Common Bile Duct; RUQ-right upper quadrant

Cholangiocarcinoma diagnosed in pregnancy/postpartum period &Symptom duration not available; NA-Details not available; CBD-Common Bile Duct; RUQ-right upper quadrant In our patient, pregnancy could have masked hepatomegaly and ascites and led to delay in establishing diagnosis. Antenatal ultrasound scans focus on fetal parameters and may not detect maternal visceral abnormalities. CT scans are contraindicated in pregnancy. Tumor markers like alpha-fetoprotein and alkaline phosphatase are elevated in normal pregnancies. Weight loss due to malignancy may not occur in a pregnant patient. Vomiting due to other causes may be attributed to pregnancy. The above factors lead to difficulty in diagnosis of malignancy in a pregnant patient. A significant proportion of antenatal checkups are conducted by primary care and family medicine physicians. Jaundice in pregnancy is associated with maternal complications and high maternal and perinatal mortality rates.[20] At primary care level, pregnant patients with jaundice should be referred to higher centers as they require multidisciplinary approach.[21]

Conclusion

Though rare, cholangiocarcinoma can occur in pregnancy and postpartum state. Symptoms and signs of a neoplastic process maybe masked during pregnancy. Low index of suspicion and limited diagnostic modalities may prevent early diagnosis of malignancy in pregnant women.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  19 in total

1.  Mixed hepatocellular carcinoma and cholangiocarcinoma during pregnancy: a case report.

Authors:  Sandro Gerli; Alessandro Favilli; Claudia Giordano; Annibale Donini; Gian Carlo Di Renzo
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2015-02-18       Impact factor: 2.435

2.  Intrahepatic cholangiocarcinoma masquerading as liver abscess.

Authors:  Vinit Shah; Anil Arora; Pankaj Tyagi; Praveen Sharma; Naresh Bansal; Vikas Singla; Rinkesh K Bansal; Varun Gupta; Ashish Kumar
Journal:  J Clin Exp Hepatol       Date:  2015-01-14

Review 3.  Liver Disease in Pregnancy and Transplant.

Authors:  Saad Alghamdi; Jaquelyn Fleckenstein
Journal:  Curr Gastroenterol Rep       Date:  2019-07-25

4.  Cancer during pregnancy and the postpartum period: A population-based study.

Authors:  Therese M-L Andersson; Anna L V Johansson; Irma Fredriksson; Mats Lambe
Journal:  Cancer       Date:  2015-03-03       Impact factor: 6.860

5.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

6.  Combined hepatocellular-cholangiocarcinoma with fever of unknown origin: a case report and review of literature.

Authors:  Changyong E; Yingjun Xie; Yongsheng Yang; Degang Ji; Wei Li; Xuewen Zhang
Journal:  Cell Biochem Biophys       Date:  2014-05       Impact factor: 2.194

7.  Intrahepatic cholangiocarcinoma masquerading as the HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) in pregnancy: case report.

Authors:  K D Balderston; K Tewari; F Azizi; J K Yu
Journal:  Am J Obstet Gynecol       Date:  1998-09       Impact factor: 8.661

8.  An Observational Study to Evaluate the Maternal and Foetal Outcomes in Pregnancies Complicated with Jaundice.

Authors:  Pradnya Changede; Niranjan Chavan; Neha Raj; Priyanka Gupta
Journal:  J Obstet Gynaecol India       Date:  2018-03-22

9.  A young lady with post-partum jaundice and right upper quadrant lump abdomen: an unusual etiology.

Authors:  Amitava Goswami; Narendra Bhargava; Sunil Dadhich; Kirti Rana Chaturvedi
Journal:  Ann Gastroenterol       Date:  2014

10.  Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis.

Authors:  Junshan Li; Tianjie Han; Linlin Xu; Xiaotian Luan
Journal:  Prz Gastroenterol       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.